SlideShare une entreprise Scribd logo
1  sur  29
Guidelines for primary and elective
 PCI WITHOUT surgery back-up & the
   related guidelines for rescue PCI


      George D. Dangas, MD, PhD, FACC
Professor of Medicine (Cardiovascular Disease)
          Mount Sinai Medical Center
                New York, NY
James B McClurken, MD, FACC, FCCP, FACS, FESC
         Director of Thoracic Surgery
  The Heart Institute, Doylestown Hospital, PA
      Professor of Cardiothoracic Surgery
          Temple University Hospital
Disclosures - McClurken

I am a Cardiothoracic Surgeon employed by the Village
   Improvement Association of Doylestown Hospital,
   Doylestown, PA.
I am co-author or reviewer for some of the ACCF/AHA
   … guidelines relevant to this topic.

I have vivid recall of the early PTCA/PCI era!
Status of Percutaneous Coronary Intervention without On-site
              Cardiac Surgical Back-up in the US




                                     Gregory J Dehmer US Cardiology, 2009;6(1):69-74
PCI in Hospitals Without On-Site Surgical
   Backup: ACC/AHA/SCAI Guideline 2012
CLASS IIa (Level of Evidence: B)
1.Primary PCI is reasonable in hospitals without on-site cardiac surgery, provided that
appropriate planning for program development has been accomplished.

CLASS IIb (Level of Evidence: B)
1.Elective PCI might be considered in hospitals without on-site cardiac surgery,
provided that appropriate planning for program development has been accomplished
and rigorous clinical and angiographic criteria are used for proper patient selection.
      (Level of Evidence: B)

CLASS III: HARM (Level of Evidence: C)
1.Primary or elective PCI should not be performed in hospitals without on-site cardiac
surgery capabilities without a proven plan for rapid transport to a cardiac surgery
operating room in a nearby hospital or without appropriate hemodynamic support
capability for transfer.


                            Levine GN et.al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary
                            Intervention. Catheter Cardiovasc Interv. 2012 Feb 15;79(3):453-95.
PCI w/o Onsite CABG Back-up

• Must have (part 1):
   – Periodic MD/NP/RN meetings to review complications
      • ? Outside participation (from CABG affiliated facility)
   – Periodic MD/NP/RN meetings to review case selection
     implications and appropriateness
      • ? Outside participation (from CABG affiliated facility)
   – Written protocol for criteria for onsite PCI performance
     per clinical syndrome (STEMI, ACS, stable)
   – Written protocol for pharmacology (admission to cath
     lab) per clinical syndrome
PCI w/o Onsite CABG Back-up
• Must have (part 2):
  – Periodic meetings (NP/PA/RN) to review
    equipment and set-up
  – Written protocol for criteria for onsite use of
    hemodynamic support (cath lab, CCU, transfer)
  – Written protocol for transfer notification,
    approval process and fast completion
     • Transfer to which hospital?
     • Transfer to which doctor?
     • Transfer on what meds or support devices?
PCI (Primary & Elective) without Surgical Back-up Policy Guidance through
                         Regulation or Legislation,
               AHA Advocacy Department; March 7, 2012



   •   States should require all PCI programs without surgical back-up
       to participate in programs like the Action Registry-Get With The
       Guidelines (AR-G), National Cardiovascular Data Registry (NCDR)
       or the Atlantic Cardiovascular Patient Outcomes Research Team
       (CPORT) to monitor their quality and outcomes, allowing
       program leaders to show their commitment to quality by
       subjecting their program performance to independent peer
       review.
   •   The programs should adhere to strict patient-selection criteria
       (e.g. exclusion of patients with EF < 30%, unprotected Left Main
       intervention, intervention on last conduit to the heart).
PCI (Primary & Elective) without Surgical Back-up Policy Guidance through
                         Regulation or Legislation,
               AHA Advocacy Department; March 7, 2012


     • Have an annual institutional PCI volume of at least
       200 to 400 cases.
     • Should include only AHA/ACC-qualified operators
       who meet standards for training and competency.
     • Should demonstrate appropriate planning for
       program development and should complete both a
       primary PCI development program and an elective
       PCI development program. Program development
       to include routine care process and case selection
       review.
     • Agree to develop and maintain a quality and error
       management program.
PCI (Primary & Elective) without Surgical Back-up Policy Guidance through
                         Regulation or Legislation,
               AHA Advocacy Department; March 7, 2012



     • Perform primary PCI 24/7.
     • Develop and maintain necessary agreements
       with a tertiary facility (which must agree to
       accept emergent and non-emergent transfers
       for additional medical care, cardiac surgery or
       intervention).
     • Develop and sustain agreements with an
       ambulance service capable of advanced life
       support and IABP transfer that guarantees a 30-
       minute-or-less response time.
Developing a Network

• Thus far we have presented the necessity of the PCI hospital
  w/o CABG back-up to belong to an affiliation network with
  CABG-able facilities.
• PCI case number is a key criterion.
• An additional source of PCI cases can be derived from another
  network:
   – PCI site is the center
   – Its non-PCI hospital affiliates participate
• The guidelines support Rescue PCI transfers after lytics
• New data support Routine Transfer
PCI in non SOS Hospitals
               1 year follow-up
[2 hospitals in demonstration project in PA]


        Alfred A. Bove, MD PhD
         Principal Investigator



              Co-investigators:
            Abul Kashem MD PhD
            Patricia McDOnnell, RN
Conclusions
• Fewer complications in selective PCI patients
• Angina persisted in <8% of the PCI patient
  population
• Mortality was low
  – Overall cardiac mortality ≤1%
  – Total non-cardiac mortality for 1-year 3.1%
• Hospitalizations were related to persistent angina
• Event-free survival suggests PCI can be performed
  safely in selective non-SOS hospitals
       Alfred A. Bove, 2 hospitals PCI w/o SOS PA demonstration project
Rescue PCI
• Definition: PCI for failure of fibrinolytics

   – Clinical failure assessed at 60-90 minutes after
     fibrinolytics
      • Persistent chest pain or other active ischemic symptoms
      • Development of complications (e.g. heart failure, shock)
      • EKG with < 50% ST resolution in lead with previous maximal
        elevations suggests absence of reperfusion
      • Other clues:
          – No “reperfusion arrhythmias” – AIVR
          – No rapid release of biomarkers
Longer-Term Follow-Up of Patients in
REACT (Rescue Angioplasty Versus Conservative
   Treatment or Repeat Thrombolysis) Trial
Long term Mortality




Adjusted Hazard ratio for
 Longer Term Mortality
2011 ACC/AHA PCI Guidelines
                             Rescue PCI
I IIa IIb III
                A strategy of immediate coronary
                angiography (or transfer for immediate
                coronary angiography) with intent to
                perform PCI is reasonable in patients
                with coronary angiography with STEMI,
                a moderate to large area of myocardium
                at risk, and evidence of failed fibrinolysis

                        Levine, Circulation 2011
2007 STEMI Update
                             Rescue PCI
                A strategy of coronary angiography with
                intent to perform PCI (or emergency CABG) is
                recommended in patients who have received
                fibrinolytic therapy and have
I IIa IIb III
                a. Cardiogenic shock in patients <75 years who are
                   suitable candidates for revascularization
I IIa IIb III
                b. Severe congestive heart failure and/or pulmonary
                   edema (Killip class III)
I IIa IIb III
                c. Hemodynamically compromising ventricular
                   arrhythmias
Routine PCI After Fibrinolysis
                 In patients whose anatomy is suitable, PCI
                 should be performed for the following
I IIa IIb III

                 Objective evidence of recurrent MI


I IIa IIb III
                  Moderate or severe spontaneous/
                  provocable myocardial ischemia during
                  recovery from STEMI
I IIa IIb III

                  Cardiogenic shock or hemodynamic instability
Pharmacoinvasive management
• A strategy for patients who cannot be offered immediate primary
  PCI
    – E.g. non PCI centers where transfer for primary PCI cannot be
      achieved in recommended times

• Fibrinolytics administered per current guidelines followed by
  transfer to PCI centers

• PCI of the infarct related artery is subsequently performed

• Strategy previously associated with bleeding complications and no
  clinical benefit
    – TIMI II trial
Early Invasive versus Standard Care
          after thrombolytics
                         TRANSFER-AMI Investigators




Primary composite of death, reinfarction, heart failure & shock at 30 days
 Cantor WJ. American College of Cardiology 2008 Scientific Sessions. March 30, 2008;
                                    Chicago, IL.
Early Invasive versus Standard Care after
                   thrombolytics
                                TRANSFER-AMI Investigators


                                    P=0.0013
                                    1059 pts




                                                      Time to PCI 192 min


Cantor WJ. American College of Cardiology 2008 Scientific Sessions. March 30, 2008;
Chicago, IL.
Ischemic Events at Follow-up in
           Pharmaco-invasive Trials




Verheugt, NEJM 2009; 360, 26: 2779-2781
2011 ACC/AHA PCI Guidelines
                Pharmaco-invasive strategy
I IIa IIb III   A strategy of coronary angiography (or
   A            transfer for coronary angiography) 3 to
                24 hours after initiating fibrinolytic
                therapy with intent to perform PCI is
                reasonable for hemodynamically stable
                patients with STEMI and evidence for
                successful fibrinolysis when angiography
                and revascularization can be performed
                as soon as logistically feasible in this
                time frame.

                      Levine, Circulation 2011
Conclusions
• PCI w/o CABG back-up onsite can be performed
• A set of related guidelines indicates the types of clinical
  protocols (critical pathways) and transferring affiliation
  agreements that ought to be in place
   – Longitudinal database participation
   – Peer review
• Development of a well-functioning network is key
• The 2012 questions are
   – Is it always appropriate?
   – Is if financially viable and under what criteria?
Planning & execution to minimize risks
Originally a PA PCI w/o
SOS demonstration
hosp.; SOS since 2000
Final thoughts ….
Make sure the transfer team is on the
 same care pathway page & ready

Contenu connexe

Tendances

07 stemi treatment in areas remote from primary pci centres
07 stemi treatment in areas remote from primary pci centres07 stemi treatment in areas remote from primary pci centres
07 stemi treatment in areas remote from primary pci centres
NPSAIC
 
Risk reduction strategies for cardiac patients
Risk reduction strategies for cardiac patientsRisk reduction strategies for cardiac patients
Risk reduction strategies for cardiac patients
Abeer Nakera
 
Preoperative assessment
Preoperative  assessmentPreoperative  assessment
Preoperative assessment
isakakinada
 
InTech-Critical_care_issues_after_major_hepatic_surgery
InTech-Critical_care_issues_after_major_hepatic_surgeryInTech-Critical_care_issues_after_major_hepatic_surgery
InTech-Critical_care_issues_after_major_hepatic_surgery
Ashok Thorat
 
A C S0104 Bleeding And Transfusion
A C S0104  Bleeding And  TransfusionA C S0104  Bleeding And  Transfusion
A C S0104 Bleeding And Transfusion
medbookonline
 

Tendances (20)

Perioperative Cardiovascular Risk assessment
Perioperative Cardiovascular Risk assessmentPerioperative Cardiovascular Risk assessment
Perioperative Cardiovascular Risk assessment
 
07 stemi treatment in areas remote from primary pci centres
07 stemi treatment in areas remote from primary pci centres07 stemi treatment in areas remote from primary pci centres
07 stemi treatment in areas remote from primary pci centres
 
Cardiac risk ,lecture presented at Palermo,Italy 2009
Cardiac risk ,lecture presented at Palermo,Italy 2009Cardiac risk ,lecture presented at Palermo,Italy 2009
Cardiac risk ,lecture presented at Palermo,Italy 2009
 
Preop evaluation of cardiac patient postd=ed for non cardiac surgery
Preop evaluation of cardiac patient postd=ed for non cardiac surgery Preop evaluation of cardiac patient postd=ed for non cardiac surgery
Preop evaluation of cardiac patient postd=ed for non cardiac surgery
 
Pre operative evaluation of the elderly
Pre operative evaluation of the elderlyPre operative evaluation of the elderly
Pre operative evaluation of the elderly
 
Risk reduction strategies for cardiac patients
Risk reduction strategies for cardiac patientsRisk reduction strategies for cardiac patients
Risk reduction strategies for cardiac patients
 
Noncardiac Surgery After PCI
Noncardiac Surgery After PCINoncardiac Surgery After PCI
Noncardiac Surgery After PCI
 
Pro Operative Cardiac Clearence For Non Cardiac Surgery
Pro Operative Cardiac Clearence For Non Cardiac SurgeryPro Operative Cardiac Clearence For Non Cardiac Surgery
Pro Operative Cardiac Clearence For Non Cardiac Surgery
 
Cardiac risk stratification
Cardiac risk stratificationCardiac risk stratification
Cardiac risk stratification
 
Preoperative assessment
Preoperative  assessmentPreoperative  assessment
Preoperative assessment
 
InTech-Critical_care_issues_after_major_hepatic_surgery
InTech-Critical_care_issues_after_major_hepatic_surgeryInTech-Critical_care_issues_after_major_hepatic_surgery
InTech-Critical_care_issues_after_major_hepatic_surgery
 
WCD
WCDWCD
WCD
 
Preop cardiovascular evaluation
Preop cardiovascular evaluationPreop cardiovascular evaluation
Preop cardiovascular evaluation
 
Penetrating thoracic injuries treatment options
Penetrating thoracic injuries treatment optionsPenetrating thoracic injuries treatment options
Penetrating thoracic injuries treatment options
 
A C S0104 Bleeding And Transfusion
A C S0104  Bleeding And  TransfusionA C S0104  Bleeding And  Transfusion
A C S0104 Bleeding And Transfusion
 
Journal
JournalJournal
Journal
 
Guias preoperatorio
Guias preoperatorioGuias preoperatorio
Guias preoperatorio
 
Alpheus trial ppt
Alpheus trial pptAlpheus trial ppt
Alpheus trial ppt
 
Antiplatelets and anticoagulants in noncardiac surgeries
Antiplatelets and anticoagulants in noncardiac surgeriesAntiplatelets and anticoagulants in noncardiac surgeries
Antiplatelets and anticoagulants in noncardiac surgeries
 
Koshy
KoshyKoshy
Koshy
 

Similaire à G dangas jmc-c lurken

Intervention treatment for acs
Intervention treatment for acsIntervention treatment for acs
Intervention treatment for acs
Kyaw Win
 
PRAMI clinical trial (for STEMI intervention)
PRAMI clinical trial (for STEMI intervention)PRAMI clinical trial (for STEMI intervention)
PRAMI clinical trial (for STEMI intervention)
Abdelkader Almanfi
 

Similaire à G dangas jmc-c lurken (20)

Acs aha 2015
Acs aha 2015Acs aha 2015
Acs aha 2015
 
Cardiac rehab
Cardiac rehabCardiac rehab
Cardiac rehab
 
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
 
Ich 2010 guidelines
Ich 2010 guidelines Ich 2010 guidelines
Ich 2010 guidelines
 
Revascularization for Ischemic Ventricular Dysfunction - REVIVED-BCIS2.pptx
Revascularization for Ischemic Ventricular Dysfunction - REVIVED-BCIS2.pptxRevascularization for Ischemic Ventricular Dysfunction - REVIVED-BCIS2.pptx
Revascularization for Ischemic Ventricular Dysfunction - REVIVED-BCIS2.pptx
 
Defer stemi
Defer stemiDefer stemi
Defer stemi
 
The age, creatinine, and ejection fraction score to risk
The age, creatinine, and ejection fraction score to riskThe age, creatinine, and ejection fraction score to risk
The age, creatinine, and ejection fraction score to risk
 
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MIFFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
 
Post pci management of acs
Post pci management of acsPost pci management of acs
Post pci management of acs
 
John Davies: Update on the ORBITA - CTO trial
John Davies: Update on the ORBITA - CTO trialJohn Davies: Update on the ORBITA - CTO trial
John Davies: Update on the ORBITA - CTO trial
 
Primary care management in Acute Coronary Syndrome
Primary care management in Acute Coronary SyndromePrimary care management in Acute Coronary Syndrome
Primary care management in Acute Coronary Syndrome
 
Intervention treatment for acs
Intervention treatment for acsIntervention treatment for acs
Intervention treatment for acs
 
Salon 2 13 kasim 14.00 15.00 john albaran
Salon 2 13 kasim 14.00 15.00 john albaranSalon 2 13 kasim 14.00 15.00 john albaran
Salon 2 13 kasim 14.00 15.00 john albaran
 
A Guide to Implementing Primary Angioplasty
A Guide to Implementing Primary Angioplasty A Guide to Implementing Primary Angioplasty
A Guide to Implementing Primary Angioplasty
 
World Heart Day 2023-Reperfusion Strategy.pptx
World Heart Day 2023-Reperfusion Strategy.pptxWorld Heart Day 2023-Reperfusion Strategy.pptx
World Heart Day 2023-Reperfusion Strategy.pptx
 
Acute coronary syndrome(STEMI GUIDELINES AND RECENT ADVANCES)
Acute coronary syndrome(STEMI GUIDELINES AND RECENT ADVANCES)Acute coronary syndrome(STEMI GUIDELINES AND RECENT ADVANCES)
Acute coronary syndrome(STEMI GUIDELINES AND RECENT ADVANCES)
 
PCI vs Fibrinolysis trails
PCI vs Fibrinolysis trailsPCI vs Fibrinolysis trails
PCI vs Fibrinolysis trails
 
Meta analysis of percutaneous ventricular restoration (pvr) therapy using the...
Meta analysis of percutaneous ventricular restoration (pvr) therapy using the...Meta analysis of percutaneous ventricular restoration (pvr) therapy using the...
Meta analysis of percutaneous ventricular restoration (pvr) therapy using the...
 
PRAMI clinical trial (for STEMI intervention)
PRAMI clinical trial (for STEMI intervention)PRAMI clinical trial (for STEMI intervention)
PRAMI clinical trial (for STEMI intervention)
 
Recent cardiology updates ehrs2018
Recent cardiology updates ehrs2018Recent cardiology updates ehrs2018
Recent cardiology updates ehrs2018
 

Plus de dwestenberger

Dehmer final--pci without onsite surgery-recent meta-analyses -final
Dehmer final--pci without onsite surgery-recent meta-analyses -finalDehmer final--pci without onsite surgery-recent meta-analyses -final
Dehmer final--pci without onsite surgery-recent meta-analyses -final
dwestenberger
 
Kutcher 11-27-12_final-x
 Kutcher 11-27-12_final-x Kutcher 11-27-12_final-x
Kutcher 11-27-12_final-x
dwestenberger
 
Commissioner of health mary o'dowd
Commissioner of health   mary o'dowdCommissioner of health   mary o'dowd
Commissioner of health mary o'dowd
dwestenberger
 
Dr ken kutscher opening remarks
Dr ken kutscher opening remarksDr ken kutscher opening remarks
Dr ken kutscher opening remarks
dwestenberger
 
Final program 11 27-12
Final program 11 27-12Final program 11 27-12
Final program 11 27-12
dwestenberger
 

Plus de dwestenberger (9)

Brindis
BrindisBrindis
Brindis
 
Aversano
AversanoAversano
Aversano
 
Dehmer final--pci without onsite surgery-recent meta-analyses -final
Dehmer final--pci without onsite surgery-recent meta-analyses -finalDehmer final--pci without onsite surgery-recent meta-analyses -final
Dehmer final--pci without onsite surgery-recent meta-analyses -final
 
Kutcher 11-27-12_final-x
 Kutcher 11-27-12_final-x Kutcher 11-27-12_final-x
Kutcher 11-27-12_final-x
 
Thomas wharton
Thomas whartonThomas wharton
Thomas wharton
 
Dennis presentation
Dennis presentationDennis presentation
Dennis presentation
 
Commissioner of health mary o'dowd
Commissioner of health   mary o'dowdCommissioner of health   mary o'dowd
Commissioner of health mary o'dowd
 
Dr ken kutscher opening remarks
Dr ken kutscher opening remarksDr ken kutscher opening remarks
Dr ken kutscher opening remarks
 
Final program 11 27-12
Final program 11 27-12Final program 11 27-12
Final program 11 27-12
 

G dangas jmc-c lurken

  • 1. Guidelines for primary and elective PCI WITHOUT surgery back-up & the related guidelines for rescue PCI George D. Dangas, MD, PhD, FACC Professor of Medicine (Cardiovascular Disease) Mount Sinai Medical Center New York, NY
  • 2. James B McClurken, MD, FACC, FCCP, FACS, FESC Director of Thoracic Surgery The Heart Institute, Doylestown Hospital, PA Professor of Cardiothoracic Surgery Temple University Hospital
  • 3. Disclosures - McClurken I am a Cardiothoracic Surgeon employed by the Village Improvement Association of Doylestown Hospital, Doylestown, PA. I am co-author or reviewer for some of the ACCF/AHA … guidelines relevant to this topic. I have vivid recall of the early PTCA/PCI era!
  • 4. Status of Percutaneous Coronary Intervention without On-site Cardiac Surgical Back-up in the US Gregory J Dehmer US Cardiology, 2009;6(1):69-74
  • 5. PCI in Hospitals Without On-Site Surgical Backup: ACC/AHA/SCAI Guideline 2012 CLASS IIa (Level of Evidence: B) 1.Primary PCI is reasonable in hospitals without on-site cardiac surgery, provided that appropriate planning for program development has been accomplished. CLASS IIb (Level of Evidence: B) 1.Elective PCI might be considered in hospitals without on-site cardiac surgery, provided that appropriate planning for program development has been accomplished and rigorous clinical and angiographic criteria are used for proper patient selection. (Level of Evidence: B) CLASS III: HARM (Level of Evidence: C) 1.Primary or elective PCI should not be performed in hospitals without on-site cardiac surgery capabilities without a proven plan for rapid transport to a cardiac surgery operating room in a nearby hospital or without appropriate hemodynamic support capability for transfer. Levine GN et.al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. Catheter Cardiovasc Interv. 2012 Feb 15;79(3):453-95.
  • 6. PCI w/o Onsite CABG Back-up • Must have (part 1): – Periodic MD/NP/RN meetings to review complications • ? Outside participation (from CABG affiliated facility) – Periodic MD/NP/RN meetings to review case selection implications and appropriateness • ? Outside participation (from CABG affiliated facility) – Written protocol for criteria for onsite PCI performance per clinical syndrome (STEMI, ACS, stable) – Written protocol for pharmacology (admission to cath lab) per clinical syndrome
  • 7. PCI w/o Onsite CABG Back-up • Must have (part 2): – Periodic meetings (NP/PA/RN) to review equipment and set-up – Written protocol for criteria for onsite use of hemodynamic support (cath lab, CCU, transfer) – Written protocol for transfer notification, approval process and fast completion • Transfer to which hospital? • Transfer to which doctor? • Transfer on what meds or support devices?
  • 8. PCI (Primary & Elective) without Surgical Back-up Policy Guidance through Regulation or Legislation, AHA Advocacy Department; March 7, 2012 • States should require all PCI programs without surgical back-up to participate in programs like the Action Registry-Get With The Guidelines (AR-G), National Cardiovascular Data Registry (NCDR) or the Atlantic Cardiovascular Patient Outcomes Research Team (CPORT) to monitor their quality and outcomes, allowing program leaders to show their commitment to quality by subjecting their program performance to independent peer review. • The programs should adhere to strict patient-selection criteria (e.g. exclusion of patients with EF < 30%, unprotected Left Main intervention, intervention on last conduit to the heart).
  • 9. PCI (Primary & Elective) without Surgical Back-up Policy Guidance through Regulation or Legislation, AHA Advocacy Department; March 7, 2012 • Have an annual institutional PCI volume of at least 200 to 400 cases. • Should include only AHA/ACC-qualified operators who meet standards for training and competency. • Should demonstrate appropriate planning for program development and should complete both a primary PCI development program and an elective PCI development program. Program development to include routine care process and case selection review. • Agree to develop and maintain a quality and error management program.
  • 10. PCI (Primary & Elective) without Surgical Back-up Policy Guidance through Regulation or Legislation, AHA Advocacy Department; March 7, 2012 • Perform primary PCI 24/7. • Develop and maintain necessary agreements with a tertiary facility (which must agree to accept emergent and non-emergent transfers for additional medical care, cardiac surgery or intervention). • Develop and sustain agreements with an ambulance service capable of advanced life support and IABP transfer that guarantees a 30- minute-or-less response time.
  • 11. Developing a Network • Thus far we have presented the necessity of the PCI hospital w/o CABG back-up to belong to an affiliation network with CABG-able facilities. • PCI case number is a key criterion. • An additional source of PCI cases can be derived from another network: – PCI site is the center – Its non-PCI hospital affiliates participate • The guidelines support Rescue PCI transfers after lytics • New data support Routine Transfer
  • 12. PCI in non SOS Hospitals 1 year follow-up [2 hospitals in demonstration project in PA] Alfred A. Bove, MD PhD Principal Investigator Co-investigators: Abul Kashem MD PhD Patricia McDOnnell, RN
  • 13. Conclusions • Fewer complications in selective PCI patients • Angina persisted in <8% of the PCI patient population • Mortality was low – Overall cardiac mortality ≤1% – Total non-cardiac mortality for 1-year 3.1% • Hospitalizations were related to persistent angina • Event-free survival suggests PCI can be performed safely in selective non-SOS hospitals Alfred A. Bove, 2 hospitals PCI w/o SOS PA demonstration project
  • 14. Rescue PCI • Definition: PCI for failure of fibrinolytics – Clinical failure assessed at 60-90 minutes after fibrinolytics • Persistent chest pain or other active ischemic symptoms • Development of complications (e.g. heart failure, shock) • EKG with < 50% ST resolution in lead with previous maximal elevations suggests absence of reperfusion • Other clues: – No “reperfusion arrhythmias” – AIVR – No rapid release of biomarkers
  • 15. Longer-Term Follow-Up of Patients in REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) Trial
  • 16. Long term Mortality Adjusted Hazard ratio for Longer Term Mortality
  • 17. 2011 ACC/AHA PCI Guidelines Rescue PCI I IIa IIb III A strategy of immediate coronary angiography (or transfer for immediate coronary angiography) with intent to perform PCI is reasonable in patients with coronary angiography with STEMI, a moderate to large area of myocardium at risk, and evidence of failed fibrinolysis Levine, Circulation 2011
  • 18. 2007 STEMI Update Rescue PCI A strategy of coronary angiography with intent to perform PCI (or emergency CABG) is recommended in patients who have received fibrinolytic therapy and have I IIa IIb III a. Cardiogenic shock in patients <75 years who are suitable candidates for revascularization I IIa IIb III b. Severe congestive heart failure and/or pulmonary edema (Killip class III) I IIa IIb III c. Hemodynamically compromising ventricular arrhythmias
  • 19. Routine PCI After Fibrinolysis In patients whose anatomy is suitable, PCI should be performed for the following I IIa IIb III Objective evidence of recurrent MI I IIa IIb III Moderate or severe spontaneous/ provocable myocardial ischemia during recovery from STEMI I IIa IIb III Cardiogenic shock or hemodynamic instability
  • 20. Pharmacoinvasive management • A strategy for patients who cannot be offered immediate primary PCI – E.g. non PCI centers where transfer for primary PCI cannot be achieved in recommended times • Fibrinolytics administered per current guidelines followed by transfer to PCI centers • PCI of the infarct related artery is subsequently performed • Strategy previously associated with bleeding complications and no clinical benefit – TIMI II trial
  • 21. Early Invasive versus Standard Care after thrombolytics TRANSFER-AMI Investigators Primary composite of death, reinfarction, heart failure & shock at 30 days Cantor WJ. American College of Cardiology 2008 Scientific Sessions. March 30, 2008; Chicago, IL.
  • 22. Early Invasive versus Standard Care after thrombolytics TRANSFER-AMI Investigators P=0.0013 1059 pts Time to PCI 192 min Cantor WJ. American College of Cardiology 2008 Scientific Sessions. March 30, 2008; Chicago, IL.
  • 23. Ischemic Events at Follow-up in Pharmaco-invasive Trials Verheugt, NEJM 2009; 360, 26: 2779-2781
  • 24. 2011 ACC/AHA PCI Guidelines Pharmaco-invasive strategy I IIa IIb III A strategy of coronary angiography (or A transfer for coronary angiography) 3 to 24 hours after initiating fibrinolytic therapy with intent to perform PCI is reasonable for hemodynamically stable patients with STEMI and evidence for successful fibrinolysis when angiography and revascularization can be performed as soon as logistically feasible in this time frame. Levine, Circulation 2011
  • 25. Conclusions • PCI w/o CABG back-up onsite can be performed • A set of related guidelines indicates the types of clinical protocols (critical pathways) and transferring affiliation agreements that ought to be in place – Longitudinal database participation – Peer review • Development of a well-functioning network is key • The 2012 questions are – Is it always appropriate? – Is if financially viable and under what criteria?
  • 26. Planning & execution to minimize risks
  • 27. Originally a PA PCI w/o SOS demonstration hosp.; SOS since 2000
  • 29. Make sure the transfer team is on the same care pathway page & ready